Azure Biotech Inc is a global biotechnology company that specializes in research & development, as well as the production and sales of diagnostic reagents, POCT analyzers and biological materials.
Azure Biotech is also heavily involved in research in the following fields: advanced rapid diagnostic reagents, rapid molecular diagnostic platforms, the development and preparation of antibodies for several illnesses, small molecular antigen synthesis, and genetic engineering. Also, Azure Biotech is committed to the research and production of in vitro diagnostic reagents and related POCT analyzer products (such as colloidal gold rapid detection reagents), quantitative determination of chemiluminescent immunoassay reagents, and bioactive materials. More than 100 products in 9 series have been successfully developed and are currently marketed, including but not limited to: pregnancy test, DOA tests, infectious disease tests, tumor marker tests, cardiac marker tests, food safety tests, biochemical reagent series, allergy tests, integrated instruments, and reagents.
Azure Biotech products are sold to more than 100 countries and regions in Europe, Asia, Africa, Oceania, and America. In particular, our drug detection reagents have won wide praise, dominating more than 60% of market share in some European countries.
Our mission is to provide excellent IVD health care products that satisfy the needs of our customers, and help contribute to the health of humanity as a whole.
Azure Bio does this by utilizing cutting-edge science, innovative thinking and reliable technology. Our labs employ efficient but continuously monitored and improved quality control systems, ensuring that everything we produce will help us achieve our mission. Azure has a vision to be the leading provider of IVD products, and in many cases around the globe, we have met and continue to maintain that vision.